MOSCOW (Sputnik) – The Russian Direct Investment Fund (RDIF) confirmed that the European Medicines Agency (EMA) held a scientific consultation for developers of Russia’s Sputnik V vaccine against the coronavirus, with recommendations expected within up to 10 days.
Earlier in the day, EMA told Sputnik it held consultations with the Russian vaccine developers on potential authorization of the vaccine for the EU market.
The fund also confirmed having filed an application for vaccine registration. RDIF went on to say that it expects the first rolling review to be held next month. The EMA will make a decision on Sputnik V vaccine authorization basing on a series of reviews, according to RDIF.
The World Health Organization will hold a “pre-submission review of Sputnik V application” on Friday, RDIF announced.
Sourse: sputniknews.com
0.00 (0%) 0 votes
